All Articles: Research
The NCPDP Foundation Board of Trustees announced it has awarded a $102,300 research grant to the University of Minnesota College of Pharmacy to evaluate the quality of data obtained from EHRs using the NCPDP/HL7 Specialty Medication Enrollment Standard.
HealthPartners is an integrated health plan offering comprehensive medication management (CMM) under a value-based care model called Partners in Excellence (PIE). In PIE, participating organizations are incentivized to conduct CMM visits and are eligible for bonus payments if they achieve quality and engagement metrics. Semi-structured, one-on-one qualitative interviews were conducted with a group of 14 pharmacists and pharmacy managers to evaluate the acceptability, appropriateness, and feasibility of the PIE program from their perspective.
U scientists are teaming up with the Mille Lacs Band of Ojibwe to investigate aspects of lung cancer and nicotine metabolism from commercial tobacco use that may be unique to the American Indian populations.
Dr. Carrie Haskell-Luevano loves being a researcher. As a professor and Philip S. Portoghese Endowed Chair in Chemical Neuroscience, she finds joy in teaching students and making discoveries alongside her laboratory staff. Read about the value she finds in her partnership with UMN Technology Commercialization.
Pharmacists can help keep tabs on the overall health of those with mental illnesses.
David Stenehjem works in the rapidly growing field of outcomes research, which guides his research on midostaurin in FLT3-mutated acute myeloid leukemia.
Federal grants are helping the U collaborate with rural partners to focus on strengthening community resources to prevent addiction and create healthy environments for those working toward recovery.
Ahmar U. Zaidi, MD, Medical Director, Clinical Development, Sickle Cell Disease Program at Agios Pharmaceuticals presented "The Sickle Caste: From a Single Mutation to Victimization and the Road Back".
The results of Phase 2 clinical trials for glaucoma drug QLS-101 have demonstrated a favorable safety and tolerability profile, according to a news release by Qlaris Bio, which licensed the drug in 2019. A positive efficacy signal was also reported.
The Midwest Antiviral Drug Discovery (AViDD) Center is part of a network of nine national centers established in response to the public health emergency.